Exelixis Inc

Exelixis insider sale: 32,110 shares by EVP Haley Patrick J. shows routine RSU liquidity, not a warning—company remains solidly bullish with steady growth.

Michael Morrissey’s rare charitable sale of 109,676 Exelixis shares—while keeping a 1.7% stake—signals strong executive confidence, boosts investor sentiment, and highlights leadership’s philanthropy amid a positive analyst upgrade and a robust biot…

Julie Smith’s bulk buys at Exelixis reveal insider confidence – buy‑back at $18‑$19, well below market, signaling potential upside amid exec sales and a biotech pipeline poised for milestones.